Reslizumab - Teva Pharmaceuticals
At a glance
- Drug Originator Celltech R&D; Schering-Plough
- Drug Licenced by Teva Pharmaceutical Industries
- Drug Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Interleukin 5 inhibitors
- USA Patent Applicants TEVA RESPIRATORY LLC
- USA Patents 30
- BLAs 1
- International Patents 417
Disclaimer